Medtronic’s most recent trend suggests a bullish bias. One trading opportunity on Medtronic is a Bull Put Spread using a strike $55.00 short put and a strike $50.00 long put offers a potential 5.93% return on risk over the next 26 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $55.00 by expiration. The full premium credit of $0.28 would be kept by the premium seller. The risk of $4.72 would be incurred if the stock dropped below the $50.00 long put strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for Medtronic is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for Medtronic is bullish.
The RSI indicator is at 70.83 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Medtronic
MDT December 21st Options Begin Trading
Mon, 21 Oct 2013 15:20:00 GMT
Forbes – Investors in Medtronic, Inc. (NYSE: MDT) saw new options become available today, for the December 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MDT options chain for the new December 21st contracts and identified one put and one call contract of particular interest. The […]
Cheney book documents his struggles with heart disease
Mon, 21 Oct 2013 14:03:10 GMT
USA TODAY – New book by former VP and his cardiologist documents his struggles with heart disease.
Medtronic First to Offer Lateral Access Procedures to All Levels of the Lower Lumbar Spine
Mon, 21 Oct 2013 14:01:01 GMT
Thomson Reuters ONE – MEMPHIS, Tenn. – Oct. 21, 2013 – Medtronic, Inc. (NYSE: MDT) the world leader in spinal technology, announced today the launch of the first procedure that allows lateral access to the most common operative …
Medtronic Launches New Device To Remove Coronary Thrombus
Mon, 21 Oct 2013 13:01:01 GMT
Thomson Reuters ONE – Long-Time Market Leader Introduces U.S. Cardiologists to Greater Power and Superior Deliverability of Next-Generation `Export Advance` Aspiration Catheter MINNEAPOLIS — Oct. 21, 2013 — With more than …
Medtronic: A Shining Pharma Investment
Fri, 18 Oct 2013 20:58:35 GMT
Seeking Alpha – Recently, Medtronic ( MDT ) received FDA approval for its innovative artificial pancreas, which automatically regulates insulin delivery for Type-1 diabetes patients. The device is already available in …
Also on Market Tamer…
Follow Us on Facebook